Intergenetics Inc is categorized under Commercial Medical Research in Oklahoma City, OK and active since 2002.
Intergenetics Inc was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Craig Shimasaki at the company’s single location by writing to 655 Research Parkway # 300, Oklahoma City, Oklahoma OK 73104 or by phoning (405) 271-1720. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Intergenetics Inc |
| Contact Person: | Craig Shimasaki |
| Address: | 655 Research Parkway # 300, Oklahoma City, Oklahoma 73104 |
| Phone Number: | (405) 271-1720 |
| Website Address: | intergenetics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417112 |
| Share This Business: |
Intergenetics Inc was started in 2002 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Craig Shimasaki for inquiries that concern Intergenetics Inc by calling the company number (405) 271-1720, as your correspondence is most welcome. Additionally, the physical location of the single location of Intergenetics Inc can be found at the coordinates 35.47412,-97.50311 as well as the street address 655 Research Parkway # 300 in Oklahoma City, Oklahoma 73104.
For its online presence, you may visit Intergenetics Inc’s website at intergenetics.com and engage with its social media outlets through on Twitter and on Facebook.